Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
John SakysCFO | Mesa LaboratoriesMLAB | Open-market sale | 06/22 | 06/23 | 2,827 sh | $89.50 | $253,016.5 | −12.5% |
Brian David ArchboldSVP Operations | Mesa LaboratoriesMLAB | Open-market sale | 06/22 | 06/23 | 2,516 sh | $89.50 | $225,182 | −28.3% |
Mesa LaboratoriesMLAB | Open-market sale | 06/22 | 06/23 | 442 sh | $89.50 | $39,559 | −18.0% | |
John SakysCFO | Mesa LaboratoriesMLAB | Open-market sale10b5-1 plan | 06/16 | 06/17 | 1,223 sh | $101.27 | $123,853.21 | −6.9% |
Brian David ArchboldSVP Operations | Mesa LaboratoriesMLAB | Open-market sale10b5-1 plan | 06/16 | 06/17 | 1,151 sh | $101.27 | $116,561.77 | −23.7% |
Mesa LaboratoriesMLAB | Open-market sale10b5-1 plan | 06/16 | 06/17 | 118 sh | $101.27 | $11,949.86 | −7.4% | |
R. Tony TripenyDirector | Mesa LaboratoriesMLAB | Open-market buy | 03/10 | 03/10 | 1,315 sh | $76.00 | $99,940 | +32.2% |
Mark Christopher CaponeDirector | Mesa LaboratoriesMLAB | Open-market buy | 03/10 | 03/10 | 1,301 sh | $76.35 | $99,331.35 | +61.1% |
Shiraz Shabanali LadiwalaDirector | Mesa LaboratoriesMLAB | Open-market buy | 03/10 | 03/10 | 3,500 sh | $72.23 | $252,805 | +69.7% |
John SakysCFO | Mesa LaboratoriesMLAB | Open-market sale | 25/06/16 | 25/06/18 | 642 sh | $97.12 | $62,351.04 | −4.8% |
Gary M. OwensPresident and CEO | Mesa LaboratoriesMLAB | Open-market sale | 25/06/16 | 25/06/18 | 1,939 sh | $97.12 | $188,315.68 | −4.1% |
Brian David ArchboldSVP Operations | Mesa LaboratoriesMLAB | Open-market sale | 25/06/16 | 25/06/18 | 472 sh | $97.12 | $45,840.64 | −45.8% |
Gary M. OwensPresident and CEO | Mesa LaboratoriesMLAB | Open-market sale10b5-1 plan | 25/03/19 | 25/03/24 | 21,000 sh | $123.91 | $2,602,110 | −32.6% |
Mesa LaboratoriesMLAB | Open-market sale | 24/10/28–24/10/29 | 24/10/29 | 5,069 sh2 trades | $112.79avg. | $571,756.14 | −10.5% | |
Brian David ArchboldSVP Operations | Mesa LaboratoriesMLAB | Open-market sale10b5-1 plan | 24/09/13 | 24/09/16 | 1,499 sh | $125.00 | $187,375 | −100.0% |
Brian David ArchboldSVP Operations | Mesa LaboratoriesMLAB | Open-market sale10b5-1 plan | 23/12/15 | 23/12/19 | 1,500 sh | $112.36 | $168,540 | −72.9% |
Mesa LaboratoriesMLAB | Open-market sale10b5-1 plan | 23/09/14–23/09/15 | 23/09/19 | 4,000 sh2 trades | $123.22avg. | $492,890 | −6.0% | |
John Bradley SchmiederDirector | Mesa LaboratoriesMLAB | Open-market sale10b5-1 plan | 23/09/13 | 23/09/14 | 3,000 sh | $123.32 | $369,960 | −4.3% |
Gary M. OwensPresident and CEO | Mesa LaboratoriesMLAB | Open-market sale10b5-1 plan | 23/09/01 | 23/09/05 | 2,000 sh | $142.82 | $285,640 | −6.2% |
Mesa LaboratoriesMLAB | Open-market sale | 23/03/22–23/03/24 | 23/03/27 | 4,628 sh3 trades | $169.50avg. | $784,447.28 | −32.3% |